Patient Advocates Request Public Hearing to Examine Court-Ordered Drug Restrictions

Drug Industry Daily
A group of hemophilia patients and activists petitioned the FDA to hold a public hearing on court-ordered drug restrictions after an intellectual property suit filed by Shire requested restricted access for the hemophilia medication Hemlibra (emicizumab-kxwh).

To View This Article:


Subscribe To Drug Industry Daily